Version 1
: Received: 19 December 2023 / Approved: 20 December 2023 / Online: 20 December 2023 (10:54:31 CET)
How to cite:
Boudovitch, D.; Sakaya, A.; Uzundurukan, A.; Leroux, J.; FUOCO, D. Review of Commercially Available Nano-Drugs and Nano-Delivery Systems: Challenges and Perspectives. Preprints2023, 2023121480. https://doi.org/10.20944/preprints202312.1480.v1
Boudovitch, D.; Sakaya, A.; Uzundurukan, A.; Leroux, J.; FUOCO, D. Review of Commercially Available Nano-Drugs and Nano-Delivery Systems: Challenges and Perspectives. Preprints 2023, 2023121480. https://doi.org/10.20944/preprints202312.1480.v1
Boudovitch, D.; Sakaya, A.; Uzundurukan, A.; Leroux, J.; FUOCO, D. Review of Commercially Available Nano-Drugs and Nano-Delivery Systems: Challenges and Perspectives. Preprints2023, 2023121480. https://doi.org/10.20944/preprints202312.1480.v1
APA Style
Boudovitch, D., Sakaya, A., Uzundurukan, A., Leroux, J., & FUOCO, D. (2023). Review of Commercially Available Nano-Drugs and Nano-Delivery Systems: Challenges and Perspectives. Preprints. https://doi.org/10.20944/preprints202312.1480.v1
Chicago/Turabian Style
Boudovitch, D., Jean-Yve Leroux and DOMENICO FUOCO. 2023 "Review of Commercially Available Nano-Drugs and Nano-Delivery Systems: Challenges and Perspectives" Preprints. https://doi.org/10.20944/preprints202312.1480.v1
Abstract
Nano-drugs and nano-delivery systems are rapidly evolving, with new strategies emerging in the current practices. The evolution of these technologies began with modifying the chemical structure, progressing to supramolecular ionic complexes, and culminating in elegant ad hoc delivery systems. Nanoparticles have numerous benefits as a carrier system for delivering therapeutic agents to intra-arterial sites. These benefits include their subcellular size, targeted surfaces, good suspensibility, and uniform dispersity, making them an ideal choice for catheter-based delivery. Despite the advancements made in the field of nano-drugs and nano-delivery systems, there are still some hurdles to overcome in terms of their commercial availability.The current review presents an updated summary of recent advancements in nano-drugs and nano-delivery systems, including their commercial availability. We aim to discuss the present challenges and prospects of commercially available nano-drugs and nano-delivery systems. Here, we provide a precise and informative overview of the current state of these technologies and underscore the potential they hold for future developments. Further, we have categorized commercially available modifications, name, parent company and their main applications in nano-drugs.
Keywords
Nano-drugs; Nanoparticle; Delivery System; Vaccine; Liposome; Exosome; Stealth Effect; SLN; Inclusion and Dispersion Systems; Solid State Reactive Mixing; Nanosome; Drug Carrier
Subject
Chemistry and Materials Science, Nanotechnology
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
